The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years...
Tag - treat multiple sclerosis
Press Releases
Research Papers
Events Calendar
Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Events
-
NextGen UGM 20252025-11-02 - 2025-11-05 -
-
MEDICA 20252025-11-17 - 2025-11-20 -
FALL 2025 Innovators Summit2025-12-02 - 2025-12-04